InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Arnold Susan Elizabeth, Vice-Président. Director active across 2 companies, notably PhaseBio Pharmaceuticals Inc. Cumulatively, 9 reports have been published. History available since 20 May 2021. The latest transaction was disclosed on 20 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
10,917 shares@ US$0.681310.5% of flowCommon StockSEC:0001169245-22-000079:0
2,559 shares@ US$2.016.8% of flowCommon StockSEC:0001169245-21-000128
2,559 shares@ US$2.016.8% of flowCommon StockSEC:0001169245-21-000128:0
4,519 shares@ US$1.749.9% of flowCommon StockSEC:0001169245-21-000089:0
4,519 shares@ US$1.749.9% of flowCommon StockSEC:0001169245-21-000089
4,519 shares@ US$1.749.9% of flowCommon StockSEC:0001169245-21-000069
4,519 shares@ US$1.749.9% of flowCommon StockSEC:0001169245-21-000069:0
5,257 shares@ US$2.8018.1% of flowCommon StockSEC:0001169245-21-000043
5,257 shares@ US$2.8018.1% of flowCommon StockSEC:0001169245-21-000043:0
9 of 9 declarations
About Arnold Susan Elizabeth
Susan Elizabeth Arnold is Vice President of Preclinical and Chemistry, as well as Senior Vice President of Technical Operations at PhaseBio Pharmaceuticals Inc. She plays a key role in product development and optimizing technical operations. Her expertise contributes to the innovation and growth of the company.
